Articles tagged with "Pharmaceutical"

Sort by

Treatments remain effective for Mpox says study  

January 15, 2023
Joint research by British and German institutions suggest that current drugs used to combat the global monkeypox outbreak remain effective.

Breast cancer studies top global clinical trials for 2022

January 15, 2023
Breast cancer remains the most studied disease according to recent global analysis of thousands of clinical trials.

The EU clinical clock is ticking

January 9, 2023
With the 31 January 2023 switch to new EU Clinical Trial Regulations fast approaching, Werner Engelbrecht explains how trial sponsors and CROs can ensure they are prepared.

NASA awaits return of landmark space experiments cargo

January 8, 2023
Samples from pioneering experiments into radiation, hydroponics and bioprospecting in microgravity environments will return to Earth this week from the International Space Station.

Chemical sector welcomes REACH deadline consultation results

January 8, 2023
Chemical sector businesses and organisations have overwhelmingly backed extension of transitional registration deadlines for the new post-Brexit UK REACH regime, in response to a Whitehall consultation process.

The science of art

December 12, 2022
The Courtauld Institute of Art’s expertise in preserving art works derives in part from its use of advanced lab techniques Of these, the most important is chromatography, explains its Head...

Mimicry with consistency

December 5, 2022
Research into neurodegenerative conditions can be hampered by difficulty accessing scalable, translatable cellbased disease models. Amanda Turner charts the hunt for solutions.

Image integrity in academic papers

November 28, 2022
Academic papers are the most important medium for introducing results to the scientific community, so researchers, editors and publishers have an ethical obligation to ensure all the data shared is...

Lab Babble: The Modern Prometheus

November 28, 2022
Not content with streamlining all scientific research, Russ Swan now offers a blueprint for human evolution.

Start-up raises £0.5 million-plus towards hard tumour immunotherapy goal

November 27, 2022
Start-up Neobe Therapeutics has raised £520K towards financing its endeavours to reduce barriers to immunotherapy in cancer patients with solid tumours.

Pin It on Pinterest